| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Proceeds from issuance of common stock-Equity Line Of Credit Agreement | - | 0 |
| Payment of stock issuance costs-Two Thousand Twenty Four Direct Offering | - | 0 |
| Payment of stock issuance costs | - | 147 |
| Net cash provided by financing activities | 7,481 | 4,612 |
| Net decrease in cash, cash equivalents and restricted cash | 2,040 | -224 |
| Cash and cash equivalents at beginning of period | 1,769 | - |
| Cash and cash equivalents at end of period | 3,809 | - |
Aspira Women's Health Inc. (AWHL)
Aspira Women's Health Inc. (AWHL)